Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000954112 | SCV001100721 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000954112 | SCV001477605 | benign | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002427387 | SCV002743871 | benign | Cardiovascular phenotype | 2020-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000954112 | SCV002821829 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | EPHB4: BS2 |
Breakthrough Genomics, |
RCV000954112 | SCV005221159 | likely benign | not provided | criteria provided, single submitter | not provided |